Brevan Howard Capital Management’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.68M Buy
8,157
+1,376
+20% +$494K 0.02% 445
2025
Q4
$2.38M Sell
6,781
-86
-1% -$31.3K 0.03% 433
2025
Q3
$2.54M Sell
6,867
-26,003
-79% -$10M 0.01% 461
2025
Q2
$13M Buy
+32,870
New +$12.3M 0.08% 136
2024
Q4
Sell
-2,679
Closed -$968K 1417
2024
Q3
$968K Buy
+2,679
New +$925K 0.01% 462
2024
Q2
Sell
-1,729
Closed -$619K 1384
2024
Q1
$619K Sell
1,729
-137
-7% -$46.1K 0.01% 390
2023
Q4
$559K Buy
+1,866
New +$524K 0.01% 431

Other funds holding SYK

Brevan Howard Capital Management's SYK Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Stryker (SYK) stake by 20% in Q1 2026, buying an estimated $494K and bringing the position to 8,157 shares worth $2.68M. The position accounts for 0.02% of the portfolio, ranked #445.

Brevan Howard Capital Management first reported a position in SYK in Q4 2023 and has held it in 7 quarters since. The position peaked at $13M in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Brevan Howard Capital Management held 8,157 shares of Stryker worth $2.68M as of Q1 2026.
  • Brevan Howard Capital Management bought 1,376 Stryker shares in Q1 2026, an estimated $494K.
  • Stryker made up 0.02% of Brevan Howard Capital Management's portfolio in Q1 2026, its #445 holding.
  • Brevan Howard Capital Management first reported a position in Stryker in Q4 2023 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Stryker position peaked at $13M in Q2 2025.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.